281 related articles for article (PubMed ID: 30311872)
1. Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand.
Singkham-In U; Chatsuwan T
J Med Microbiol; 2018 Dec; 67(12):1667-1672. PubMed ID: 30311872
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of
Lasarte-Monterrubio C; Guijarro-Sánchez P; Bellés A; Vázquez-Ucha JC; Arca-Suárez J; Fernández-Lozano C; Bou G; Beceiro A;
Microbiol Spectr; 2022 Feb; 10(1):e0273421. PubMed ID: 35138195
[TBL] [Abstract][Full Text] [Related]
4. Molecular Epidemiology of Emerging Carbapenem Resistance in
Chen FJ; Huang WC; Liao YC; Wang HY; Lai JF; Kuo SC; Lauderdale TL; Sytwu HK
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670429
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of carbapenem non-susceptible Acinetobacter nosocomialis in a medical center in Taiwan.
Yang YS; Lee YT; Wang YC; Chiu CH; Kuo SC; Sun JR; Yin T; Chen TL; Lin JC; Fung CP; Chang FY
Infect Genet Evol; 2015 Apr; 31():305-11. PubMed ID: 25724091
[TBL] [Abstract][Full Text] [Related]
6. Worldwide dissemination of acquired carbapenem-hydrolysing class D β-lactamases in Acinetobacter spp. other than Acinetobacter baumannii.
Zander E; Fernández-González A; Schleicher X; Dammhayn C; Kamolvit W; Seifert H; Higgins PG
Int J Antimicrob Agents; 2014 Apr; 43(4):375-7. PubMed ID: 24612983
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.
Chusri S; Chongsuvivatwong V; Rivera JI; Silpapojakul K; Singkhamanan K; McNeil E; Doi Y
Antimicrob Agents Chemother; 2014 Jul; 58(7):4172-9. PubMed ID: 24820079
[TBL] [Abstract][Full Text] [Related]
8. Dissemination of bla
Leungtongkam U; Thummeepak R; Wongprachan S; Thongsuk P; Kitti T; Ketwong K; Runcharoen C; Chantratita N; Sitthisak S
Microb Drug Resist; 2018; 24(1):55-62. PubMed ID: 28594634
[TBL] [Abstract][Full Text] [Related]
9. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
[TBL] [Abstract][Full Text] [Related]
10. [Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
Ciftci IH; Aşık G; Karakeçe E; Oksüz L; Yağcı S; Sesli Çetin E; Ozdemir M; Atasoy AR; Koçoğlu E; Gül M; Kurtoğlu MG; Köksal Çakırlar F; Seyrek A; Berktaş M; Gültepe B; Ayyildiz A
Mikrobiyol Bul; 2013 Oct; 47(4):592-602. PubMed ID: 24237428
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
[TBL] [Abstract][Full Text] [Related]
12. First Report of the Carbapenemase Gene
D'Souza R; Pinto NA; Higgins PG; Hwang I; Yong D; Choi J; Lee K; Chong Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264850
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009).
Schleicher X; Higgins PG; Wisplinghoff H; Körber-Irrgang B; Kresken M; Seifert H
Clin Microbiol Infect; 2013 Aug; 19(8):737-42. PubMed ID: 23034071
[TBL] [Abstract][Full Text] [Related]
14. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
[TBL] [Abstract][Full Text] [Related]
15. Emergence of carbapenem-resistant Acinetobacter pittii carrying the bla
Brasiliense DM; Lima KVB; Pérez-Chaparro PJ; Mamizuka EM; de Oliveira Souza C; Dutra LMG; McCulloch JA
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):82-84. PubMed ID: 30149987
[TBL] [Abstract][Full Text] [Related]
16. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
Rieber H; Frontzek A; Pfeifer Y
Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
[TBL] [Abstract][Full Text] [Related]
17. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
18. Characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex isolates from nosocomial bloodstream infections in southern Iran.
Pourabbas B; Firouzi R; Pouladfar G
J Med Microbiol; 2016 Mar; 65(3):235-239. PubMed ID: 26747061
[TBL] [Abstract][Full Text] [Related]
19. Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore.
Koh TH; Tan TT; Khoo CT; Ng SY; Tan TY; Hsu LY; Ooi EE; Van Der Reijden TJ; Dijkshoorn L
Epidemiol Infect; 2012 Mar; 140(3):535-8. PubMed ID: 21733253
[TBL] [Abstract][Full Text] [Related]
20. Increasing prevalence of blaOXA-23-carrying Acinetobacter baumannii and the emergence of blaOXA-182-carrying Acinetobacter nosocomialis in Korea.
Lee Y; Kim YR; Kim J; Park YJ; Song W; Shin JH; Uh Y; Lee K; Lee SH; Cho JH; Yong D; Jeong SH; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):160-3. PubMed ID: 23891219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
